Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Serum protein profiles to identify head and neck cancer.

Wadsworth JT, Somers KD, Cazares LH, Malik G, Adam BL, Stack BC Jr, Wright GL Jr, Semmes OJ.

Clin Cancer Res. 2004 Mar 1;10(5):1625-32.

2.

Identification of patients with head and neck cancer using serum protein profiles.

Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, Wright GL Jr, Semmes OJ.

Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):98-104.

PMID:
14732777
3.

Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy.

Ciavarra RP, Holterman DA, Brown RR, Mangiotti P, Yousefieh N, Wright GL Jr, Schellhammer PF, Glass WF, Somers KD.

J Immunother. 2004 Jan-Feb;27(1):13-26.

PMID:
14676630
4.

Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer.

Ciavarra RP, Brown RR, Holterman DA, Garrett M, Glass WF 2nd, Wright GL Jr, Schellhammer PF, Somers KD.

Cancer Immunol Immunother. 2003 Sep;52(9):535-45.

PMID:
14627125
5.

Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.

Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL Jr, Schellhammer PF, Qian J, Ciavarra RP.

Int J Cancer. 2003 Dec 10;107(5):773-80.

6.

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.

Incognito LS, Cazares LH, Schellhammer PF, Kuban DA, Van Dyk EO, Moriarty RP, Wright GL Jr, Somers KD.

Int J Oncol. 2000 Oct;17(4):761-9.

PMID:
10995889
7.

Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer.

Ciavarra RP, Somers KD, Brown RR, Glass WF, Consolvo PJ, Wright GL, Schellhammer PF.

Cancer Res. 2000 Apr 15;60(8):2081-4.

8.

Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.

Wu Y, Palad AJ, Wasilenko WJ, Blackmore PF, Pincus WA, Schechter GL, Spoonster JR, Kohn EC, Somers KD.

Clin Cancer Res. 1997 Nov;3(11):1915-21.

9.

Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor.

Gresham J, Margiotta P, Palad AJ, Somers KD, Blackmore PF, Wright GL Jr, Schellhammer PF, Wasilenko WJ.

Int J Cancer. 1998 Sep 11;77(6):923-7.

10.

Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro.

Patel AS, Schechter GL, Wasilenko WJ, Somers KD.

Oncogene. 1998 Jun 25;16(25):3227-32.

11.

Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines.

Lambert PA, Somers KD, Kohn EC, Perry RR.

Surgery. 1997 Aug;122(2):372-8; discussion 378-9.

PMID:
9288143
12.

Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP.

Wasilenko WJ, Cooper J, Palad AJ, Somers KD, Blackmore PF, Rhim JS, Wright GL Jr, Schellhammer PF.

Prostate. 1997 Feb 15;30(3):167-73.

PMID:
9122041
13.

Fibrin deposition in Peyronie's disease plaque.

Somers KD, Dawson DM.

J Urol. 1997 Jan;157(1):311-5.

PMID:
8976287
14.

Proposal: trauma as the cause of the Peyronie's lesion.

Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM.

J Urol. 1997 Jan;157(1):285-90.

PMID:
8976281
15.

Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines.

Wasilenko WJ, Palad AJ, Somers KD, Blackmore PF, Kohn EC, Rhim JS, Wright GL Jr, Schellhammer PF.

Int J Cancer. 1996 Oct 9;68(2):259-64.

16.

Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.

Patel AM, Incognito LS, Schechter GL, Wasilenko WJ, Somers KD.

Oncogene. 1996 Jan 4;12(1):31-5.

PMID:
8552396
17.

Frequent p53 mutations in head and neck cancer.

Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G.

Cancer Res. 1992 Nov 1;52(21):5997-6000.

18.

Genetic alterations in head and neck cancer.

Somers KD, Schechter GL.

Otolaryngol Clin North Am. 1992 Oct;25(5):1065-71.

PMID:
1408191
19.

Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes.

Blackmore PF, Oakes SG, Somers KD.

Oncogene. 1992 Oct;7(10):2053-7.

PMID:
1408146
20.

Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice.

Brothman AR, Wilkins PC, Sales EW, Somers KD.

J Urol. 1991 May;145(5):1088-91.

PMID:
2016798
21.

Growth and histopathology of human head and neck squamous cell carcinoma implanted intraorally in nude mice.

Sales EW, Fitch KA, Sudetic PA, Schechter GL, Faulconer RJ, Somers KD.

Otolaryngol Head Neck Surg. 1991 Mar;104(3):351-7.

PMID:
1902936
22.

Peyronie's disease: pathophysiology.

Devine CJ Jr, Somers KD, Ladaga LE.

Prog Clin Biol Res. 1991;370:355-8. No abstract available.

PMID:
1924469
23.

Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

Somers KD, Cartwright SL, Schechter GL.

Oncogene. 1990 Jun;5(6):915-20.

PMID:
2193294
24.

Beta-tubulin epitope expression in normal and malignant epithelial cells.

Scott CA, Walker CC, Neal DA, Harper CE, Bloodgood RA, Somers KD, Mills SE, Rebhun LI, Levine PA.

Arch Otolaryngol Head Neck Surg. 1990 May;116(5):583-9.

PMID:
1691648
25.

Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma.

Brothman AR, Lesho LJ, Somers KD, Wright GL Jr, Merchant DJ.

Int J Cancer. 1989 Nov 15;44(5):898-903.

PMID:
2583869
26.

Isolation and characterization of collagen in Peyronie's disease.

Somers KD, Sismour EN, Wright GL Jr, Devine CJ Jr, Gilbert DA, Horton CE.

J Urol. 1989 Mar;141(3):629-31.

PMID:
2918606
27.

Cytogenetic analysis of four primary prostatic cultures.

Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladaga LE, Merchant DJ.

Cancer Genet Cytogenet. 1989 Feb;37(2):241-8.

PMID:
2467737
28.

Growth of head and neck squamous cell carcinoma in nude mice: potentiation of laryngeal carcinoma by 17 beta-estradiol.

Somers KD, Koenig M, Schechter GL.

J Natl Cancer Inst. 1988 Jul 6;80(9):688-91.

PMID:
3373559
29.

Binding of human IgG to cultured urogenital tumor cells.

Wright GL Jr, Beckett ML, Campbell AE, Gardner KG, Somers KD.

J Natl Cancer Inst. 1987 Jun;78(6):1061-8.

PMID:
3473247
30.

Chromosome abnormalities in Peyronie's disease.

Somers KD, Winters BA, Dawson DM, Leffell MS, Wright GL Jr, Devine CJ Jr, Gilbert DA, Horton CE.

J Urol. 1987 Apr;137(4):672-5.

PMID:
3560320
31.
32.

An in vitro model of epithelial cell neoplastic progression: growth properties and polypeptide composition of cell lines.

Somers KD, Murphey MM, Stark DG.

Prog Nucleic Acid Res Mol Biol. 1983;29:249-52. No abstract available.

PMID:
6665168
33.
34.

Non-association of Peyronie's disease with HLA B7 cross-reactive antigens.

Leffell MS, Devine CJ Jr, Horton CE, Somers KD, Dawson D, Vande Berg JS, Bluemink GG, Wright GI Jr.

J Urol. 1982 Jun;127(6):1223-4. No abstract available.

PMID:
6979636
35.

Cell culture of Peyronie's disease plaque and normal penile tissue.

Somers KD, Dawson DM, Wright GL Jr, Leffell MS, Rowe MJ, Bluemink GG, Vande Berg JS, Gleischman SH, Devine CJ Jr, Horton CE.

J Urol. 1982 Mar;127(3):585-8.

PMID:
7038152
36.

Mechanisms of calcification in Peyronie's disease.

Vande Berg JS, Devine CJ Jr, Horton CE, Somers KD, Wright GL Jr, Leffell MS, Dawson DM, Gleischman SH, Rowe MJ.

J Urol. 1982 Jan;127(1):52-4.

PMID:
7057504
37.

Peyronie's disease: an electron microscopic study.

Vande Berg JS, Devine CJ, Horton CE, Somers KD, Wright GL Jr, Leffell MS, Dawson DM, Gleischman SH, Rowe MJ.

J Urol. 1981 Sep;126(3):333-6. No abstract available.

PMID:
7196961
38.

Cytochalasin B-response of human tumor cell cultures.

Somers KD, Murphey MM.

Cell Biol Int Rep. 1980 Dec;4(12):1143-9. No abstract available.

PMID:
7460028
39.
41.

Cytoplasmic methylation of mature 5.8 S ribosomal RNA.

Nazar RN, Sitz TO, Somers KD.

J Mol Biol. 1980 Sep 5;142(1):117-21. No abstract available.

PMID:
7431406
42.

Cytochalasin B-induced multinucleation of human tumor and normal cell cultures.

Somers KD, Murphey MM.

Cell Biol Int Rep. 1980 May;4(5):487-95.

PMID:
7397790
43.

Retention of phospholipid acyl groups is not characteristic of neoplastic cells in culture.

Rosenthal MD, Somers KD.

Biochim Biophys Acta. 1979 Aug 30;574(2):356-60.

PMID:
486516
45.

Cyclic AMP-mediated transformation of rat cells transformed by temperature-sensitive mouse sarcoma virus.

Somers KD, Rachmeler M, Christensen M.

Nature. 1975 Sep 4;257(5521):58-60. No abstract available.

PMID:
169472
46.
47.

Fucosylglycolipids in cells transformed by a temperature-sensitive mutant of murine sarcoma virus.

Steiner SM, Melnick JL, Kit S, Somers KD.

Nature. 1974 Apr 19;248(5450):682-4. No abstract available.

PMID:
4364434
48.

Characterization of the major viral polypeptide in cells transformed by wild-type and temperature-sensitive murine sarcoma virus.

Spira G, Dreesman GR, Benyesh-Melnick M, Kit S, Somers KD.

Intervirology. 1974;4(2):99-109. No abstract available.

PMID:
4141344
49.

Temperature-dependent alterations in 2-deoxyglucose uptake in rat cells transformed by a cold-sensitive murine sarcoma virus mutant.

May JT, Somers KD, Kit S.

Int J Cancer. 1973 Mar 15;11(2):377-84. No abstract available.

PMID:
4364262
50.

Control of gene expression in rat cells transformed by a cold-sensitive murine sarcoma virus (MSV) mutant.

Somers KD, May JT, Kit S.

Intervirology. 1973;1(3):176-84. No abstract available.

PMID:
4359760

Supplemental Content

Loading ...
Support Center